Mark Cuban on Drugs, Investing, and Advice for Jeff Bezos
The big three healthcare companies aren’t paying much attention to Mark Cuban’s new health care venture, Cost Plus Drugs. But their margins could mean a huge opportunity for the new start-up. Chris Hill caught up with Cuban to discuss: - Why he’s able to sell a leukemia drug for thousands of dollars less than…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Motley Fool Hidden Gems Investing
See all episodes →Why the Companies Most at Risk of Disruption Are Usually the Most Successful Ones
10 Tips for Harvesting Investment Losses
Flying Cars, Smart Homes, and Cracks in the AI Boom
Similar episodes from other shows
More like Motley Fool Hidden Gems Investing →
Mark Cuban on High Drug Prices, Taxing Billionaires, and 2028
Mark Cuban Shares His Plan For Fixing Drug Prices in America | The Real Eisman Playbook Ep 50
20VC: Mark Cuban on Reshaping the Pharmaceuticals Industry, How To Hire and Build Truly Great Teams and What Brand Really Means Today and How To Build One Successfully
Mark Cuban on why AI is the future and Facebook’s Libra isn’t
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.